Home » FDA APPROVES GENERIC REMERON
FDA APPROVES GENERIC REMERON
Par Pharmaceutical has announced that its licensing partner Amide Pharmaceutical
has received FDA approval to market a generic version of Remeron, an antidepressant
made by Akzo Nobel unit Organon International.
Par said Amide will market a generic version of Organon's orally disintegrating
Remeron SolTab, also know by its active ingredient mirtazapine, in 15-, 30-
and 45-mg doses. Amide will begin shipping all doses of the drug shortly.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
07May
-
14May
-
30May